XML 45 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCK COMPENSATION PLANS (Details Textual) (USD $)
3 Months Ended 12 Months Ended 1 Months Ended 3 Months Ended 12 Months Ended 1 Months Ended 3 Months Ended 1 Months Ended
Feb. 28, 2013
Feb. 29, 2012
Nov. 30, 2012
Mar. 31, 2011
Xenogenics Corporation [Member]
Feb. 28, 2013
Xenogenics Corporation [Member]
Feb. 29, 2012
Xenogenics Corporation [Member]
Feb. 03, 2011
Xenogenics Corporation [Member]
Oct. 31, 2010
Xenogenics Corporation [Member]
Nov. 30, 2010
Executive Officer [Member]
Xenogenics Corporation [Member]
Mar. 31, 2011
Officers and Members of Scientific Advisory Board [Member]
Xenogenics Corporation [Member]
Feb. 28, 2013
Officers and Members of Scientific Advisory Board [Member]
Xenogenics Corporation [Member]
Feb. 29, 2012
Officers and Members of Scientific Advisory Board [Member]
Xenogenics Corporation [Member]
Feb. 29, 2012
Replacement Options [Member]
Feb. 28, 2012
Replacement Options [Member]
Feb. 28, 2013
Equity Incentive Plan 2004 [Member]
Dec. 02, 2012
Equity Incentive Plan 2004 [Member]
Dec. 02, 2011
Equity Incentive Plan 2004 [Member]
Jul. 11, 2011
Equity Incentive Plan 2004 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized             8,000,000 5,000,000               1,500,000 1,500,000 70,974,213
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant                             51,380,266      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0     3,000,000         2,500,000       1,250,000          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price                 $ 0.246 $ 0.246       $ 0.253        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Outstanding Number                 500,000                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest Outstanding Number                 2,000,000                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Granted in Period Fair Value                 $ 576,250 $ 692,700     $ 298,500          
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date                 Nov. 30, 2015                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value                 $ 0.2305 $ 0.2309     $ 0.2338          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 1.89%   1.62%           1.23% 2.20%     0.84%          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 147.00%   141.00%           165.00% 165.00%     170.00%          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 10 years   10 years           5 years 5 years     5 years          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 0.00%   0.00%           0.00% 0.00%     0.00%          
Allocated Share-based Compensation Expense 4,406 11,619       1,553         95,462 59,278            
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Stock Options 18,000                   36,000              
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition 1 year 10 months 24 days       7 months 6 days                          
Closing Price Share $ 0.0038                                  
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent         100.00%                          
Share-based Compensation Arrangement by Share-based Payment Award, Option, Maximum Term         10 years                          
Share-based Compensation Arrangement by Share-based Payment Award, Original Terms of Plan         A 10% stockholder shall not be granted an ISO unless the exercise price of such option is at least 110% of the fair market value of Xenogenics' common stock                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Percentage                   50.00%                
Stock Issuance Qualified Financing Milestone for Proceeds                   5,000,000                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period                   1,500,000                
Reversal Allocated Share-based Compensation Expense         $ 57,725             $ 57,725